4Morgan GJ,Davies FE,Gregory WM,et al.Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma:MRC Myeloma IX trial[J].Blood,2012,119(23):5374-5383.
5Q Ye,B Chen,Z Tong,et al.Thalidomide reduces IL-18,IL-8and TNF-release from alveolar macrophages in interstitial lung disease[J].Eur Respir J,2006,28(4):824-831.
6Sameer AB,Francisco H.The emerging role of lenalidomide in the management of lymphoid malignancies[J].Therapeutic Advances in Hematology,2011,2(1):45-53.
7Breitkreutz I,Raab MS,Vallet S,et al.Lenalidomide inhibits osteoclastogenesis,survival factors and bone-remodeling markers in multiple myeloma[J].Leukemia,2008,22(10):1925-1932.
8Evangelos T,Lia A.Moulopoulos,et al.Advances in Imaging and the Management of Myeloma Bone Disease[J].J Clin Oncol,2011,29(14):1907-1915.
9Heider U,Kaiser M,Muller C,et al.Botrezomib increases osteoblast activity in myeloma patients irrespective of response to treatment[J].Eur J Haematol,2006,77(3):233-238.
10M Mohr,D Pillich,M Kirsch,et al.Percutaneous Balloon Kyphoplasty with the Patient under Intravenous Analgesia and Sedation:A Feasibility Study[J].AJNR Am J Neuroradiol,2011,32(4):649-653.
